Tower Research Capital LLC (Trc) Cyma Bay Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.63 - $24.47 $109,072 - $211,322	8,636 Added 459.12%	10,517 $248,000
Q3 2023 Nov 14, 2023	SELL	$10.86 - $17.62 $260,618 - $422,844	-23,998 Reduced 92.73%	1,881 $28,000
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $179,660 - $263,358	24,051 Added 1315.7%	25,879 $283,000
Q1 2023 May 09, 2023	SELL	$5.88 - $9.59 $1,346 - $2,196	-229 Reduced 11.13%	1,828 $16,000
Q4 2022 Feb 10, 2023	SELL	$3.22 - $6.27 $14,393 - $28,026	-4,470 Reduced 68.48%	2,057 $13,000
Q3 2022 Nov 10, 2022	SELL	$2.77 - $4.25 $16,229 - $24,900	-5,859 Reduced 47.3%	6,527 $23,000
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $24,073 - $47,446	-13,996 Reduced 53.05%	12,386 $36,000
Q1 2022 May 12, 2022	BUY	$2.77 - $3.64 $60,355 - $79,311	21,789 Added 474.4%	26,382 $82,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $26,007 - $37,039	-8,052 Reduced 63.68%	4,593 $16,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $23,700 - $30,188	-6,830 Reduced 35.07%	12,645 $46,000
Q2 2021 Aug 16, 2021	BUY	$3.94 - $4.92 $51,283 - $64,038	13,016 Added 201.52%	19,475 $85,000
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $43,260 - $66,986	-10,227 Reduced 61.29%	6,459 $29,000
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $335,336 - $528,462	-58,523 Reduced 77.81%	16,686 $95,000
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $200,375 - $436,962	60,354 Added 406.29%	75,209 $545,000
Q2 2020 Aug 13, 2020	BUY	$1.41 - $4.25 $13,151 - $39,639	9,327 Added 168.72%	14,855 $52,000
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $6,910 - $11,166	5,528 New	5,528 $8,000
Q4 2019 Feb 07, 2020	SELL	$1.33 - $5.93 $15,893 - $70,863	-11,950 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$5.12 - $7.21 $61,184 - $86,159	11,950 New	11,950 $61,000
Q4 2018 Feb 14, 2019	SELL	$6.54 - $11.74 $20,483 - $36,769	-3,132 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.88 - $14.52 $34,076 - $45,476	3,132 New	3,132 $35,000
Q2 2018 Aug 15, 2018	SELL	$10.66 - $14.38 $57,393 - $77,421	-5,384 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $24,417 - $41,129	2,713 Added 101.57%	5,384 $70,000
Q4 2017 Feb 09, 2018	SELL	$7.67 - $9.31 $17,081 - $20,733	-2,227 Reduced 45.47%	2,671 $25,000
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $29,143 - $40,457	4,898	4,898 $39,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account